Progresión en glaucoma. Guía de práctica clínica

  1. Laia Jaumandreu 14
  2. Alfonso Antón 234
  3. Marta Pazos 45
  4. Ignacio Rodriguez-Una 46
  5. Iñaki Rodriguez Agirretxe 47
  6. José María Martínez-De-La-Casa 49
  7. Miriam Eleonora Ayala 24
  8. M. Parrilla-Vallejo 48
  9. Agnieszka Anna Dyrda 2
  10. Laura Díez-Álvarez 14
  11. Gema Rebolleda 14
  12. Francisco José Muñoz-Negrete 14
  1. 1 Hospital Ramón y Cajal
    info

    Hospital Ramón y Cajal

    Madrid, España

    ROR https://ror.org/050eq1942

  2. 2 Institut Català de la Retina (ICR), Barcelona, España
  3. 3 Universitat Internacional de Catalunya
    info

    Universitat Internacional de Catalunya

    Barcelona, España

    ROR https://ror.org/00tse2b39

  4. 4 Instituto de Salud Carlos III
    info

    Instituto de Salud Carlos III

    Madrid, España

    ROR https://ror.org/00ca2c886

  5. 5 Hospital Clinic Barcelona
    info

    Hospital Clinic Barcelona

    Barcelona, España

    ROR https://ror.org/02a2kzf50

  6. 6 Universidad de Oviedo
    info

    Universidad de Oviedo

    Oviedo, España

    ROR https://ror.org/006gksa02

  7. 7 Hospital Universitario de Donostia
    info

    Hospital Universitario de Donostia

    San Sebastián, España

    ROR https://ror.org/04fkwzm96

  8. 8 Hospital Universitario Virgen Macarena
    info

    Hospital Universitario Virgen Macarena

    Sevilla, España

    ROR https://ror.org/016p83279

  9. 9 Hospital Clínico San Carlos de Madrid
    info

    Hospital Clínico San Carlos de Madrid

    Madrid, España

    ROR https://ror.org/04d0ybj29

Revista:
Archivos de la Sociedad Española de Oftalmologia

ISSN: 0365-6691

Any de publicació: 2023

Volum: 98

Número: 1

Pàgines: 40-57

Tipus: Article

DOI: 10.1016/J.OFTAL.2022.05.002 DIALNET GOOGLE SCHOLAR

Altres publicacions en: Archivos de la Sociedad Española de Oftalmologia

Objectius de Desenvolupament Sostenible

Resum

Objective To provide general recommendations that serve as a guide for the evaluation and management of glaucomatous progression in daily clinical practice based on the existing quality of clinical evidence. Methods After defining the objectives and scope of the guide, the working group was formed and structured clinical questions were formulated following the PICO (Patient, Intervention, Comparison, Outcomes) format. Once all the existing clinical evidence had been independently evaluated with the AMSTAR 2 (Assessment of Multiple Systematic Reviews) and Cochrane «Risk of bias» tools by at least two reviewers, recommendations were formulated following the Scottish Intercollegiate Guideline network (SIGN) methodology. Results Recommendations with their corresponding levels of evidence that may be useful in the interpretation and decision-making related to the different methods for the detection of glaucomatous progression are presented. Conclusions Despite the fact that for many of the questions the level of scientific evidence available is not very high, this clinical practice guideline offers an updated review of the different existing aspects related to the evaluation and management of glaucomatous progression.